nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR2B—Sorafenib—thyroid cancer	0.34	0.381	CbGbCtD
Ergotamine—HTR2C—Sorafenib—thyroid cancer	0.222	0.248	CbGbCtD
Ergotamine—CYP1A2—Sorafenib—thyroid cancer	0.0806	0.0902	CbGbCtD
Ergotamine—ABCB1—Sorafenib—thyroid cancer	0.0705	0.0789	CbGbCtD
Ergotamine—CYP3A4—Vandetanib—thyroid cancer	0.0701	0.0784	CbGbCtD
Ergotamine—ABCB1—Doxorubicin—thyroid cancer	0.0428	0.0478	CbGbCtD
Ergotamine—CYP3A4—Sorafenib—thyroid cancer	0.0422	0.0473	CbGbCtD
Ergotamine—CYP3A4—Doxorubicin—thyroid cancer	0.0256	0.0287	CbGbCtD
Ergotamine—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	3.99e-05	0.000376	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—AKT1—thyroid cancer	3.92e-05	0.00037	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—HIF1A—thyroid cancer	3.92e-05	0.00037	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SST—thyroid cancer	3.91e-05	0.000369	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TERT—thyroid cancer	3.85e-05	0.000363	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—HRAS—thyroid cancer	3.8e-05	0.000359	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CDK1—thyroid cancer	3.8e-05	0.000359	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CCND1—thyroid cancer	3.78e-05	0.000357	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—RXRA—thyroid cancer	3.78e-05	0.000356	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	3.76e-05	0.000355	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CDK1—thyroid cancer	3.74e-05	0.000353	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—AKT1—thyroid cancer	3.7e-05	0.000349	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	3.68e-05	0.000347	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	3.66e-05	0.000346	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—PTEN—thyroid cancer	3.65e-05	0.000344	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—thyroid cancer	3.63e-05	0.000343	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—NRAS—thyroid cancer	3.6e-05	0.00034	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	3.6e-05	0.00034	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TERT—thyroid cancer	3.58e-05	0.000338	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CCND1—thyroid cancer	3.57e-05	0.000337	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—AKT1—thyroid cancer	3.56e-05	0.000336	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	3.52e-05	0.000333	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.51e-05	0.000331	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	3.48e-05	0.000328	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—HRAS—thyroid cancer	3.47e-05	0.000328	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	3.46e-05	0.000326	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	3.45e-05	0.000326	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—PTEN—thyroid cancer	3.44e-05	0.000325	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	3.42e-05	0.000323	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	3.4e-05	0.000321	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—AKT1—thyroid cancer	3.36e-05	0.000317	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TPR—thyroid cancer	3.32e-05	0.000313	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—BRAF—thyroid cancer	3.31e-05	0.000313	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	3.31e-05	0.000312	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.26e-05	0.000308	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NRAS—thyroid cancer	3.26e-05	0.000307	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—BRAF—thyroid cancer	3.24e-05	0.000306	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	3.24e-05	0.000306	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	3.23e-05	0.000305	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TERT—thyroid cancer	3.12e-05	0.000294	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.11e-05	0.000293	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TERT—thyroid cancer	3.1e-05	0.000293	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—KRAS—thyroid cancer	3.1e-05	0.000292	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	3.09e-05	0.000292	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NRAS—thyroid cancer	3.07e-05	0.00029	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—AKT1—thyroid cancer	3.07e-05	0.000289	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NRG1—thyroid cancer	3.05e-05	0.000288	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—BRAF—thyroid cancer	3.05e-05	0.000288	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	3.03e-05	0.000286	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	3.02e-05	0.000285	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	3e-05	0.000283	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.98e-05	0.000282	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	2.97e-05	0.00028	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	2.97e-05	0.00028	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.97e-05	0.00028	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.96e-05	0.000279	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	2.94e-05	0.000277	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	2.84e-05	0.000268	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	2.84e-05	0.000268	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—KRAS—thyroid cancer	2.8e-05	0.000264	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.79e-05	0.000263	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—thyroid cancer	2.75e-05	0.00026	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TERT—thyroid cancer	2.74e-05	0.000259	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	2.73e-05	0.000258	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	2.72e-05	0.000257	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TERT—thyroid cancer	2.7e-05	0.000254	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—KRAS—thyroid cancer	2.64e-05	0.000249	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	2.64e-05	0.000249	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—HRAS—thyroid cancer	2.63e-05	0.000249	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	2.63e-05	0.000248	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2.62e-05	0.000247	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	2.62e-05	0.000247	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—RXRA—thyroid cancer	2.61e-05	0.000246	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	2.6e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	2.58e-05	0.000243	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	2.58e-05	0.000243	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	2.56e-05	0.000242	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TPR—thyroid cancer	2.56e-05	0.000241	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	2.52e-05	0.000238	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	2.52e-05	0.000238	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.52e-05	0.000238	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	2.51e-05	0.000237	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	2.5e-05	0.000236	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—thyroid cancer	2.49e-05	0.000235	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.48e-05	0.000234	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	2.47e-05	0.000233	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	2.46e-05	0.000232	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	2.45e-05	0.000232	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	2.45e-05	0.000231	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCND1—thyroid cancer	2.42e-05	0.000228	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARG—thyroid cancer	2.38e-05	0.000225	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—HRAS—thyroid cancer	2.38e-05	0.000225	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	2.37e-05	0.000224	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCND1—thyroid cancer	2.37e-05	0.000223	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	2.35e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—thyroid cancer	2.35e-05	0.000222	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	2.35e-05	0.000221	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	2.34e-05	0.000221	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PTEN—thyroid cancer	2.33e-05	0.00022	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—thyroid cancer	2.33e-05	0.000219	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.33e-05	0.000219	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.31e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	2.31e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PTEN—thyroid cancer	2.29e-05	0.000216	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	2.28e-05	0.000215	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	2.27e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	2.26e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.25e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—HRAS—thyroid cancer	2.25e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	2.23e-05	0.00021	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCND1—thyroid cancer	2.22e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	2.22e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	2.21e-05	0.000208	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—BRAF—thyroid cancer	2.17e-05	0.000205	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	2.15e-05	0.000203	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PTEN—thyroid cancer	2.15e-05	0.000203	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	2.15e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	2.13e-05	0.000201	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—thyroid cancer	2.1e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	2.09e-05	0.000198	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	2.09e-05	0.000197	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—RXRA—thyroid cancer	2.09e-05	0.000197	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NRAS—thyroid cancer	2.08e-05	0.000196	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	2.07e-05	0.000195	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	2.07e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NRAS—thyroid cancer	2.04e-05	0.000192	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.03e-05	0.000191	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	2e-05	0.000188	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.99e-05	0.000188	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.99e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—thyroid cancer	1.98e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.95e-05	0.000184	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	1.95e-05	0.000184	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.94e-05	0.000183	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.94e-05	0.000183	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.92e-05	0.000181	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.92e-05	0.000181	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.92e-05	0.000181	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.91e-05	0.000181	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.91e-05	0.000181	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.88e-05	0.000177	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.87e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.87e-05	0.000176	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.86e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.83e-05	0.000173	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.8e-05	0.00017	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.8e-05	0.00017	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.79e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.79e-05	0.000169	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	1.78e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.78e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.78e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.76e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.75e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.74e-05	0.000164	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.73e-05	0.000163	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1.72e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.7e-05	0.00016	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.69e-05	0.000159	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.69e-05	0.000159	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.66e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1.66e-05	0.000156	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—thyroid cancer	1.65e-05	0.000156	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.65e-05	0.000156	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.64e-05	0.000155	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.64e-05	0.000154	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.63e-05	0.000154	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	1.62e-05	0.000153	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.62e-05	0.000152	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.61e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.61e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.59e-05	0.00015	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.58e-05	0.000149	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.58e-05	0.000149	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.56e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.56e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.55e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.54e-05	0.000146	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	1.53e-05	0.000145	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.53e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.53e-05	0.000144	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.52e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.51e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.5e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.49e-05	0.000141	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.49e-05	0.000141	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	1.48e-05	0.00014	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.47e-05	0.000139	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.47e-05	0.000139	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.47e-05	0.000138	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.46e-05	0.000138	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.44e-05	0.000136	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	0.000134	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.4e-05	0.000132	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.38e-05	0.000131	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	0.000129	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.36e-05	0.000129	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	1.36e-05	0.000129	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—thyroid cancer	1.34e-05	0.000127	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.34e-05	0.000127	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	0.000126	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.33e-05	0.000126	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.33e-05	0.000125	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—thyroid cancer	1.32e-05	0.000124	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.32e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	1.31e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	1.3e-05	0.000123	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.3e-05	0.000122	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	1.27e-05	0.00012	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	1.24e-05	0.000117	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	1.23e-05	0.000116	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.22e-05	0.000115	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.19e-05	0.000112	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.18e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	1.18e-05	0.000111	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.17e-05	0.000111	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.15e-05	0.000109	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	1.15e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	0.000107	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTEN—thyroid cancer	1.13e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	1.13e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	1.13e-05	0.000107	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.13e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	1.08e-05	0.000102	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	9.91e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—thyroid cancer	1.04e-05	9.84e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	1.04e-05	9.81e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.04e-05	9.77e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—thyroid cancer	1.03e-05	9.68e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.02e-05	9.59e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	1e-05	9.48e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	1e-05	9.47e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	9.98e-06	9.42e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HRAS—thyroid cancer	9.98e-06	9.41e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	9.82e-06	9.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	9.61e-06	9.07e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	9.55e-06	9.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—thyroid cancer	9.43e-06	8.9e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	9.34e-06	8.81e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTEN—thyroid cancer	9.03e-06	8.52e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	8.93e-06	8.43e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—thyroid cancer	8.81e-06	8.31e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	8.67e-06	8.18e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	8.49e-06	8.01e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.99e-06	7.54e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	7.88e-06	7.44e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTEN—thyroid cancer	6.97e-06	6.58e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—thyroid cancer	6.52e-06	6.15e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—thyroid cancer	5.21e-06	4.91e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—thyroid cancer	4.02e-06	3.79e-05	CbGpPWpGaD
